Vytorin/Zetia Rx Decline Prompts Schering-Plough To Issue Monthly Updates
Executive Summary
Schering-Plough says it will soon start providing monthly updates on prescription rates for its two cholesterol drugs Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe) to help ease the minds of anxious investors